Disclaimer: For full disclosure, Wild Microbes is a portfolio company of Climate Capital, where Michael works as a General Partner and Jenny works as a Managing Partner.

CC Pod is not investment advice and is intended for informational and entertainment purposes only. You should do your own research and make your own independent decisions when considering any investment decision.

Subscribe to CC Pod wherever you listen to your podcasts:

In the latest episode of the Climate Capital podcast, hosts Michael and Jenny engage in an insightful conversation with Ben Kramer, the co-founder of Wild Microbes. Based in Cambridge, Massachusetts, Wild Microbes is on a unique mission: harnessing the incredible potential of microbes to create sustainable products.

TL;DL (too long; didn’t listen):

Kramer, a Stanford graduate, outlines Wild Microbes' ambitious vision to replace environmentally destructive products in the supply chain with biologically engineered solutions. He explains the concept of bioproduction, illustrating how over 60% of physical goods in our supply chain can be made biologically. The potential scope of biomanufacturing is broad, ranging from producing dyes and pigments to ingredients for food and cosmetics.

One significant challenge that Wild Microbes addresses within the biotech industry is improving the efficiency and effectiveness of the fermentation process. The company pioneers the use of novel microbes, sourced from diverse environments, to enhance the fermentation process. Their approach involves identifying microbes that naturally thrive in conditions similar to those within a fermentation tank, transforming biomanufacturing challenges into opportunities.

Kramer also highlights the commercial traction that Wild Microbes is currently gaining. Companies in the food, cosmetics, and chemical sectors are showing interest, eager to launch their own bio-based products.

The work of Wild Microbes stands as a testament to the power of innovative biotechnology in creating a more sustainable future. Focusing on harnessing the potential of microbes, the company is driving changes within the biotech industry and making significant contributions to the fight against climate change. The prospect is exciting, making us anticipate what the future of sustainable product development might hold.

Get full access to Climate Capital at climatecap.substack.com/subscribe